A technique to prepare boronated B72.3 monoclonal antibody for boron neutron capture therapy
Authors:
- Howard S. RosenzweigHRHoward S. Rosenzweig
- Michael W. EpperlyMEMichael W. Epperly
- William D. BloomerWBWilliam D. Bloomer
- 31 January 1993
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 20 (1) , 1-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Boronation of antibodies with mercaptoundecahydro-closo-dodecaborate(2-) anion for potential use in boron neutron capture therapyApplied Radiation and Isotopes, 1987
- Current status of 10B-neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Specific Killing Effect of 10B1-Para-boronophenylalanine in Thermal Neutron Capture Therapy of Malignant Melanoma: In Vitro Radiobiological EvaluationJournal of Investigative Dermatology, 1982
- Synthesis and properties of boron and silicon substituted uracil or 2′-deoxyuridineTetrahedron Letters, 1978
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967
- Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron 10Cancer, 1955
- The Possible Use of Neutron-Capturing Isotopes such as Boron in the Treatment of NeoplasmsJournal of Neurosurgery, 1952